Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
AbbVie Inc.
IndexS&P 500 P/E21.73 EPS (ttm)2.59 Insider Own0.06% Shs Outstand1.59B Perf Week3.99%
Market Cap89.70B Forward P/E14.42 EPS next Y3.90 Insider Trans20.71% Shs Float1.57B Perf Month-3.41%
Income4.17B PEG2.35 EPS next Q0.77 Inst Own84.40% Short Float7.04% Perf Quarter4.09%
Sales19.26B P/S4.66 EPS this Y-23.10% Inst Trans4.56% Short Ratio7.74 Perf Half Y13.97%
Book/sh3.27 P/B17.21 EPS next Y23.70% ROA14.50% Target Price64.80 Perf Year20.18%
Cash/sh6.43 P/C8.75 EPS next 5Y9.23% ROE92.70% 52W Range44.82 - 59.58 Perf YTD10.03%
Dividend1.68 P/FCF40.29 EPS past 5Y0.00% ROI23.20% 52W High-5.52% Beta-
Dividend %2.98% Quick Ratio2.70 Sales past 5Y- Gross Margin76.40% 52W Low25.58% ATR1.73
Employees25000 Current Ratio2.80 Sales Q/Q5.00% Oper. Margin31.20% RSI (14)52.07 Volatility4.36% 3.04%
OptionableYes Debt/Eq2.83 EPS Q/Q3.00% Profit Margin21.70% Rel Volume1.22 Prev Close54.41
ShortableYes LT Debt/Eq2.77 EarningsOct 23 BMO Payout61.80% Avg Volume14.30M Price56.29
Recom1.80 SMA200.10% SMA500.74% SMA2007.63% Volume17,500,902 Change3.46%
28-Jul-14Upgrade UBS Neutral → Buy $57 → $67
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
21-Oct-14 06:47PM  Celgene Rises 8% In Two Days On Crohn's Disease Drug Data Investor's Business Daily
04:46PM  Winners and Losers Emerge In Wake of Treasury's New Tax Rules at The Wall Street Journal
04:20PM  AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend Zacks
02:20PM  AbbVie Inc. -- Moody's: AbbVie shareholder payouts credit negative at Moody's
11:32AM  Video: Celgene Reports More Good Crohn's Drug Data at Investor's Business Daily
11:03AM  AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
10:59AM  RPT-AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
10:58AM  -AbbVie CEO Gonzalez loses Shire, but wins praise for gutsy move Reuters
09:33AM  Chipotle gets smoked; McDonald's sales struggle; Apple gets iPhone pop Hot Stock Minute
09:29AM  Markets open for trading: AbbVie/Shire deal scrapped CNBC
09:14AM  Story Stocks from Briefing.com Briefing.com
07:41AM  [video] AbbVie Officially Scraps Shire Tax Inversion Deal at Bloomberg
06:48AM  Wall Street reacts to big earnings reports; CVS Health's latest move on tobacco; Staples gets hacked Yahoo Finance
06:02AM  ABBVIE INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statements an EDGAR Online
04:59AM  [video] ASOS Profit Falls 14% After Disruptive Fire at Bloomberg
20-Oct-14 09:30PM  AbbVie CEO Gonzalez loses Shire, but wins praise for gusty move Reuters
09:01PM  AbbVie and Shire agree to end $52-billion deal at Los Angeles Times
08:20PM  AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion Benzinga
07:21PM  AbbVie scraps Shire deal, boosts dividend at USA TODAY
07:02PM  AbbVie formally scuttles deal to buy Shire at MarketWatch
06:43PM  Inversion Implosion: AbbVie-Shire Merger Officially Dead at Forbes
06:40PM  [$$] AbbVie, Shire Terminate Deal at The Wall Street Journal
06:27PM  AbbVie to pay Shire $1.64B fee over nixed merger AP
06:26PM  [audio] Newscast: AbbVie and Shire breakup at MarketWatch
06:05PM  AbbVie and Shire Agree to Terminate Their Deal at New York Times
05:59PM  AbbVie hits Treasury as Shire deal dies at Financial Times
05:45PM  Brown & Brown Inc Earnings Call scheduled for 5:45 pm ET today CCBN
05:42PM  AbbVie says $55 billion acquisition of Shire officially dead Reuters
05:40PM  AbbVie, Shire terminate proposed merger, inversion at MarketWatch
05:35PM  AbbVie Ends Purchase of Shire on U.S. Tax Rule Changes at Bloomberg
05:31PM  AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend PR Newswire
05:12PM  Announcement Of Termination Of Proposed AbbVie And Shire Transaction PR Newswire
04:06PM  Taking Stock: Sonenshine, McCracken Agree M&A Between Innings at Bloomberg
03:31PM  Paulsons Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire at New York Times
01:53PM  Top Allergan holder Paulson urges deal with Shire -sources Reuters
01:52PM  Paulson & Co. pushes for Allergan merger with Shire: report at MarketWatch
12:15PM  [video] Report: Paulson pushing Allergan-Shire merger at CNBC
11:33AM  Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked! at TheStreet
11:16AM  Celgene's Crohn's Disease Drug Hits Its Marks at Investor's Business Daily
04:12AM  Pfizer/AZ chase may be off as pharma deals falter at CNBC
01:04AM  IRS Blocks Inversions, So AbbVie Pays $1.64 Billion Kill Fee To Shire...And Deducts It at Forbes
19-Oct-14 01:46PM  Long-term reforms of US tax system required to stop 'deserters' at Financial Times
18-Oct-14 03:04PM  We May Have an Investable Bottom; Smoke Always Clears: Jim Cramer's Best Blogs TheStreet
02:13AM  [$$] Last Week at Barrons.com
01:14AM  [$$] Another Manic Stocktober at Barrons.com
17-Oct-14 05:22PM  Pfizer's AstraZeneca pursuit knocked by Shire deal collapse at Financial Times
04:06PM  Paulsons bet turns sour as AbbVie reconsiders its Shire bid Market Realist
03:30PM  Gilead's Harvoni Receives Notice of Compliance from Canada Zacks
02:23PM  [video] Opinion: Abbvie: The Failed AbbVie Deal Slammed Markets at MarketWatch
12:37PM  Dept. of Irony: AbbVie Can Take Tax Write-Off for Fees On Busted Shire Deal at The Wall Street Journal
09:59AM  Quote of the Week: AbbVie's About Face and Management Credibility at The Wall Street Journal
09:44AM  UPDATE: Bank Of America Reiterates On AbbVie On Move To Standalone Valuation Benzinga
08:35AM  UBSs Big List of Quality Stocks to Buy Now at 24/7 Wall St.
04:26AM  Yara of Norway and CF Industries Call Off Merger Talks at New York Times
02:00AM  [$$] Collapse of AbbVie-Shire Deal Leaves Scars at The Wall Street Journal
01:15AM  PRESS DIGEST - Wall Street Journal - Oct 17 Reuters
16-Oct-14 08:16PM  PRESS DIGEST- British Business - Oct 17 Reuters
08:10PM  AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb? at TheStreet
08:06PM  [$$] Collapse of AbbVie-Shire Deal Leaves Scars at The Wall Street Journal
08:00PM  AbbVie urges shareholders to reject Shire deal due to tax rule change at Los Angeles Times
05:46PM  AbbVie's Termination Fee Is the Third Largest Ever Paid at The Wall Street Journal
04:48PM  Medicine prices at risk under Pacific trade draft-critics Reuters
03:13PM  The Best-Selling Biologic Drugs at Forbes
03:11PM  Hedge funds just cant catch a break this month at MarketWatch
01:31PM  Some inversion deals may survive tax changes at Financial Times
12:35PM  Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout Zacks
12:30PM  European stocks retreat deeper into correction territory at MarketWatch
11:50AM  [video] Jobless Claims at 14-Year Low at Bloomberg
10:49AM  [$$] Shire Looks Well-Equipped to Fly Solo at The Wall Street Journal
10:37AM  Banks could miss out on $135 mln fees as Abbvie drops Shire deal Reuters
10:37AM  How Will AbbVie (ABBV) Stock React Today to Abandoned Shire Deal? at TheStreet
10:34AM  [$$] AbbVie Drops Plan to Buy Shire at The Wall Street Journal
10:12AM  [video] Goldman Sachs 3Q Profit Tops Estimates by 48% at Bloomberg
10:10AM  Wall Street Drops on Continued Global Concerns at Fox Business
09:59AM  AbbVie sours on $55B Shire deal after tax changes AP
09:53AM  AbbVie board rejects tax-cutting inversion plan at USA TODAY
09:27AM  AbbVie on Why It Called Off Its Deal with Shire at The Wall Street Journal
09:10AM  AbbVie Abandons Shire Takeover Plans as Tax Benefits Recede at TheStreet
09:06AM  AbbVie's board recommends shareholders nix Shire tax inversion deal at Los Angeles Times
09:01AM  AbbVie board recommends shareholders vote against Shire deal at MarketWatch
07:58AM  AbbVie board ditches planned $55 billion Shire acquisition Reuters
07:51AM  AbbVie board ditches planned $55 bln Shire acquisition Reuters
07:10AM  End of the road for inversions? Abbvie drops $55 billion Shire bid at Fortune
06:30AM  ABBVIE INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:24AM  AbbVie Board Recommends Holders Vote Against Shire Deal at Bloomberg
06:00AM  [video] AbbVie Board Recommends Vote Against Shire Deal at Bloomberg
04:12AM  AbbVie board abandons $55 billion Shire merger CNNMoney.com
02:57AM  AbbVie drops proposed $54bn Shire deal at Financial Times
02:49AM  Shire-AbbVie deal collapses: What next? at CNBC
02:31AM  [video] Will Tax Rules Derail AbbVie-Shire Deal? at Bloomberg
01:22AM  AbbVie Board To Shareholders: Vote No On Shire Buy at Investor's Business Daily
01:19AM  [$$] AbbVie Board Recommends Shareholders Vote Against Shire Acquisition at The Wall Street Journal
01:17AM  [$$] AbbVie Flip-Flop Hands U.S. Government Tax-Deal Victory at The Wall Street Journal
01:13AM  PRESS DIGEST - Wall Street Journal - Oct 16 Reuters
12:55AM  AbbVie recommends stockholders to reject Shire deal Reuters
12:34AM  AbbVie Board Recommends Shareholders Reject Shire Acquisition at New York Times
12:17AM  [$$] Shire Says It Waives Three-Day Notice Period for AbbVie Board Meeting at The Wall Street Journal
15-Oct-14 11:53PM  AbbVie Board Recommends Stockholders Vote Against Shire Transaction PR Newswire
09:35PM  U.S. Tax Crackdown Is Said to Sink AbbVie Deal at New York Times
07:14PM  Market indexes dive but pare earlier big losses at USA TODAY
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Synthroid to treat hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. It has a strategic collaboration with Infinity Pharmaceuticals, Inc.; and a research and development collaboration with California Life Sciences LLC. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM